Voyager Therapeutics Inc (OQ:VYGR)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for VYGR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Khwaja Omar Direct Ownership Common Stock S - Open market or private sale -3,500 $12.96
Apr 7/20 Apr 3/20 Hesslein Robert W. Direct Ownership Common Stock S - Open market or private sale -3,091 $8.51
Feb 12/20 Feb 10/20 Dorval Allison Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 55,000  
Feb 12/20 Feb 10/20 Dorval Allison Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 27,500  
Feb 12/20 Feb 10/20 Hesslein Robert W. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 55,000  
Feb 12/20 Feb 10/20 Hesslein Robert W. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 27,500  
Feb 12/20 Feb 10/20 Khwaja Omar Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 60,000  
Feb 12/20 Feb 10/20 Khwaja Omar Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 30,000  
Feb 12/20 Feb 10/20 Turenne Andre Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 162,500  
Feb 12/20 Feb 10/20 Turenne Andre Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 81,250  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for VYGR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Khwaja Omar Direct Ownership Common Stock S - Open market or private sale -3,500 $12.96
Apr 7/20 Apr 3/20 Hesslein Robert W. Direct Ownership Common Stock S - Open market or private sale -3,091 $8.51
Feb 12/20 Feb 10/20 Dorval Allison Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 55,000  
Feb 12/20 Feb 10/20 Dorval Allison Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 27,500  
Feb 12/20 Feb 10/20 Hesslein Robert W. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 55,000  
Feb 12/20 Feb 10/20 Hesslein Robert W. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 27,500  
Feb 12/20 Feb 10/20 Khwaja Omar Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 60,000  
Feb 12/20 Feb 10/20 Khwaja Omar Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 30,000  
Feb 12/20 Feb 10/20 Turenne Andre Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 162,500  
Feb 12/20 Feb 10/20 Turenne Andre Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 81,250  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $VYGR

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)